{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:03:28Z","timestamp":1791169408340,"version":"4.1.0"},"reference-count":176,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.blre.2012.01.001","type":"journal-article","created":{"date-parts":[[2012,3,19]],"date-time":"2012-03-19T23:33:02Z","timestamp":1332199982000},"page":"123-135","source":"Crossref","is-referenced-by-count":170,"title":["The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia"],"prefix":"10.1016","volume":"26","author":[{"given":"Anthony V.","family":"Moorman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2012.01.001_bb0905","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","year":"2008"},{"key":"10.1016\/j.blre.2012.01.001_bb0910","series-title":"Cancer Cytogenetics","first-page":"233","article-title":"Acute Lymphoblastic Leukaemia","author":"Harrison","year":"2009"},{"key":"10.1016\/j.blre.2012.01.001_bb0015","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.leu.2402849","article-title":"Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases","volume":"17","author":"Harewood","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0020","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-2141.2005.05497.x","article-title":"Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study","volume":"129","author":"Harrison","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2012.01.001_bb0025","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1182\/blood.V92.2.574","article-title":"Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia","volume":"92","author":"Pallisgaard","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0030","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1046\/j.1365-2141.1997.d01-2096.x","article-title":"Frequency of CBF beta\/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials. The MRC Adult Leukaemia Working Party","volume":"96","author":"Langabeer","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2012.01.001_bb0035","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/gcc.20671","article-title":"High hyperdiploid childhood acute lymphoblastic leukemia","volume":"48","author":"Paulsson","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.blre.2012.01.001_bb0040","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2141.2004.04948.x","article-title":"Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia","volume":"125","author":"Harrison","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2012.01.001_bb0045","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1182\/blood-2003-04-1299","article-title":"A report from the LALA-94 and LALA-SA groups on hypodiploidy with 30 to 39 chromosomes and near-triploidy: 2 possible expressions of a sole entity conferring poor prognosis in adult acute lymphoblastic leukemia (ALL)","volume":"104","author":"Charrin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.seminhematol.2008.09.005","article-title":"Global genomic characterization of acute lymphoblastic leukemia","volume":"46","author":"Mullighan","year":"2009","journal-title":"Semin Hematol"},{"key":"10.1016\/j.blre.2012.01.001_bb0055","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.blre.2012.01.001_bb0060","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1182\/blood-2007-05-088310","article-title":"Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray","volume":"111","author":"Kawamata","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0065","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1038\/sj.onc.1210190","article-title":"Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization","volume":"26","author":"Strefford","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.blre.2012.01.001_bb0070","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/gcc.20818","article-title":"Evaluation of Multiplex Ligation-dependent Probe Amplification (MLPA) as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukaemia","volume":"49","author":"Schwab","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.blre.2012.01.001_bb0915","series-title":"Acute Lymphoblastic Leukaemia. Professional Guidelines for Clinical Cytogenetics: Association for Clinical Cytogenetics - www.cytogenetics.org.uk","year":"2011"},{"key":"10.1016\/j.blre.2012.01.001_bb0080","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1182\/blood.V86.11.4263.bloodjournal86114263","article-title":"High-frequency of t(12;21) in childhood B-lineage acute lymphoblastic-leukemia","volume":"86","author":"Romana","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0085","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/gcc.2870090307","article-title":"t(12;21): a new recurrent translocation in acute lymphoblastic leukemia","volume":"9","author":"Romana","year":"1994","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.blre.2012.01.001_bb0090","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1073\/pnas.92.11.4917","article-title":"Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia","volume":"92","author":"Golub","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2012.01.001_bb0095","first-page":"1985","article-title":"TEL\/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis","volume":"9","author":"Shurtleff","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-2141.2001.02668.x","article-title":"Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol","volume":"113","author":"Hann","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2012.01.001_bb0105","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1182\/blood.V90.12.4933","article-title":"Incidence of TEL\/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse","volume":"90","author":"Harbott","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0110","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2141.2008.06980.x","article-title":"Outcome of ETV6\/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival","volume":"140","author":"Forestier","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2012.01.001_bb0115","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1470-2045(10)70066-8","article-title":"Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97\/99 randomised trial","volume":"11","author":"Moorman","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.blre.2012.01.001_bb0120","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2009-10-248146","article-title":"Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study","volume":"115","author":"Conter","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0125","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1056\/NEJMoa0900386","article-title":"Treating childhood acute lymphoblastic leukemia without cranial irradiation","volume":"360","author":"Pui","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2012.01.001_bb0130","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1200\/JCO.2007.14.3552","article-title":"Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study","volume":"26","author":"Rubnitz","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2012.01.001_bb0920","first-page":"1094","article-title":"TEL\/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia","volume":"96","author":"Ramakers-van Woerden","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0140","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1182\/blood-2005-08-3451","article-title":"Prospective analysis of TEL\/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95\u201301","volume":"107","author":"Loh","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0925","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/sj.leu.2402435","article-title":"ETV6\/AML1 fusion by FISH in adult acute lymphoblastic leukemia","volume":"16","author":"Jabbar Al Obaidi","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0150","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1182\/blood.V116.21.524.524","article-title":"Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia Patients on the International UKALLXII\/E2993 Trial: No Difference in Results Between B Cell Immunophenotypic Subgroups","volume":"116","author":"Litzow","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0155","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc1816","article-title":"Infection, immune responses and the aetiology of childhood leukaemia","volume":"6","author":"Greaves","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.blre.2012.01.001_bb0160","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/sj.leu.2403471","article-title":"Incidence and relevance of secondary chromosome abnormalities in childhood TEL\/AML1+ acute lymphoblastic leukemia: an interphase FISH analysis","volume":"18","author":"Attarbaschi","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0165","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/sj.leu.2404083","article-title":"Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome","volume":"20","author":"Stams","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0170","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cancergencyto.2008.12.003","article-title":"Involvement of der(12)t(12;21)(p13;q22) and as well as additional rearrangements of chromosome 12 homolog in ETV6\/RUNX1-positive acute lymphoblastic leukemia","volume":"190","author":"Stanchescu","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.blre.2012.01.001_bb0175","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1182\/blood.V112.11.430.430","article-title":"The spectrum and prognostic relevance of additional abnormalities, involving 12p and 21q, in children with ETV6-RUNX1 positive acute lymphoblastic leukaemia (ALL)","volume":"112","author":"Moorman","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0180","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1365-2141.2011.08729.x","article-title":"Native ETV6 deletions accompanied by ETV6-RUNX1 rearrangements are associated with a favourable prognosis in childhood acute lymphoblastic leukaemia: a candidate for prognostic marker","volume":"155","author":"Ko","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2012.01.001_bb0185","doi-asserted-by":"crossref","first-page":"21719","DOI":"10.1073\/pnas.1006981107","article-title":"Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia","volume":"107","author":"Paulsson","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2012.01.001_bb0190","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood-2006-10-051912","article-title":"Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 Trial","volume":"109","author":"Moorman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0195","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1182\/blood-2003-04-1128","article-title":"Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia","volume":"102","author":"Moorman","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0200","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/bmj.2.6151.1529","article-title":"Prognostic implications of chromosomal findings in acute lymphoblastic leukaemia at diagnosis","volume":"2","author":"Secker-Walker","year":"1978","journal-title":"Br Med J"},{"key":"10.1016\/j.blre.2012.01.001_bb0205","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/gcc.20451","article-title":"Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia","volume":"46","author":"Heerema","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.blre.2012.01.001_bb0210","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.leu.2403673","volume":"19","author":"Sutcliffe","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0215","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2141.2000.02153.x","article-title":"Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods","volume":"110","author":"Forestier","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2012.01.001_bb0220","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1182\/blood.V85.3.751.bloodjournal853751","article-title":"Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study","volume":"85","author":"Kaspers","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0225","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3109\/10428199809057610","article-title":"Accumulation of methotrexate polyglutamates, ploidy and trisomies of both chromosomes 4 and 10 in lymphoblasts from children with B-progenitor cell acute lymphoblastic leukemia: a pediatric oncology group study","volume":"31","author":"Whitehead","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2012.01.001_bb0230","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood.V80.5.1316.1316","article-title":"Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (>50 chromosomes) B-lineage acute lymphoblastic leukemia: A Pediatric Oncology Group study","volume":"80","author":"Whitehead","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0235","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1172\/JCI117552","article-title":"Blast cell methotrexate-polyglutamate accumulation in-vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic-leukemia","volume":"94","author":"Synold","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2012.01.001_bb0240","first-page":"213","article-title":"Heterogeneity of hyperdiploid (51\u201367) childhood acute lymphoblastic leukemia","volume":"10","author":"Raimondi","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0245","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1200\/JCO.2000.18.9.1876","article-title":"Prognostic impact of trisomies of chromosomes 10, 17 and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (>50 chromosomes)","volume":"18","author":"Heerema","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2012.01.001_bb0250","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood.V87.4.1211.bloodjournal8741211","article-title":"Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis","volume":"87","author":"Hunger","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0255","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/gcc.20431","article-title":"Molecular cytogenetic characterisation of TCF3 (E2A)\/19p13.3 rearrangements in B-cell precursor acute lymphoblastic leukaemia","volume":"46","author":"Barber","year":"2007","journal-title":"Genes Chromosomes and Cancer"},{"key":"10.1016\/j.blre.2012.01.001_bb0260","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.leu.2401988","article-title":"Detection of E2A translocations in leukemias via fluorescence in situ hybridization","volume":"15","author":"Boomer","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0265","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood.V79.7.1781.1781","article-title":"Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia","volume":"79","author":"Privitera","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0270","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1182\/blood-2006-01-024729","article-title":"Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)","volume":"109","author":"Schultz","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0275","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3324\/haematol.11239","article-title":"Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children","volume":"92","author":"Kager","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2012.01.001_bb0280","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/leu.2009.42","article-title":"Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)\/TCF3-PBX1","volume":"23","author":"Jeha","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0930","first-page":"3135","article-title":"Cytogenetic Abnormalities in Adult Acute Lymphoblastic Leukemia: Correlations with Hematologic Findings and Outcome. A Collaborative Study of the Groupe Francais de Cytogenetique Hematologique","volume":"87","author":"GFCH","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0290","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1182\/blood-2004-07-2922","article-title":"A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol","volume":"105","author":"Mancini","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0295","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1365-2141.1997.d01-2053.x","article-title":"Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party","volume":"96","author":"Secker-Walker","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2012.01.001_bb0300","first-page":"363","article-title":"Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia","volume":"6","author":"Secker-Walker","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0305","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1126\/science.1386162","article-title":"Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia","volume":"257","author":"Inaba","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.blre.2012.01.001_bb0310","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1182\/blood.V83.10.2970.2970","article-title":"Two types of genomic rearrangements create alternative E2A-HLF fusion proteins in t(17;19)-ALL","volume":"83","author":"Hunger","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0315","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2141.2001.02643.x","article-title":"The Leukaemia Research Fund\/United Kingdom Cancer Cytogenetics Group karyotype database in acute lymphoblastic leukaemia: a valuable resource for patient management","volume":"113","author":"Harrison","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2012.01.001_bb0320","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1182\/blood-2003-09-3022","article-title":"Regulation of annexin II by cytokine-initiated signaling pathways and E2A-HLF oncoprotein","volume":"103","author":"Matsunaga","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0325","first-page":"422","article-title":"Characterization of the t(17;19) translocation by gene-specific fluorescent in situ hybridization-based cytogenetics and detection of the E2A-HLF fusion transcript and protein in patients' cells","volume":"91","author":"Yeung","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2012.01.001_bb0330","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.leu.2404150","article-title":"The MLL recombinome of acute leukemias","volume":"20","author":"Meyer","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0335","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/leu.2009.33","article-title":"New insights to the MLL recombinome of acute leukemias","volume":"23","author":"Meyer","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0340","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2141.2010.08459.x","article-title":"Mechanisms of leukemogenesis by MLL fusion proteins","volume":"152","author":"Marschalek","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2012.01.001_bb0345","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(07)61126-X","article-title":"A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial","volume":"370","author":"Pieters","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2012.01.001_bb0350","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(02)08782-2","article-title":"Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region","volume":"359","author":"Pui","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2012.01.001_bb0355","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.leu.2401016","article-title":"The translocations, t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3): a cytogenetic and clinical profile of 53 patients","volume":"12","author":"Moorman","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0360","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/sj.leu.2403629","article-title":"Derivative chromosome 9 deletions are a significant feature of childhood Philadelphia chromosome positive acute lymphoblastic leukaemia","volume":"19","author":"Robinson","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0365","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06866","article-title":"BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros","volume":"453","author":"Mullighan","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.blre.2012.01.001_bb0370","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1182\/blood-2009-07-232124","article-title":"A population-based cytogenetic study of adults with acute lymphoblastic leukemia","volume":"115","author":"Moorman","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0375","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1182\/blood-2008-04-149286","article-title":"Patients' age and BCR-ABL frequency in adult B-precursor ALL: a retrospective analysis from the GMALL study group","volume":"112","author":"Burmeister","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0380","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","article-title":"Translation of the Philadelphia chromosome into therapy for CML","volume":"112","author":"Druker","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0385","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1200\/JCO.2008.21.2514","article-title":"Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study","volume":"27","author":"Schultz","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2012.01.001_bb0390","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2141.2011.08783.x","volume":"154","author":"Rives","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2012.01.001_bb0935","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1182\/asheducation-2009.1.371","article-title":"Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)","author":"Ottmann","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.blre.2012.01.001_bb0400","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1182\/blood-2006-07-038299","article-title":"Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia","volume":"110","author":"Nachman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0405","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1182\/blood-2011-01-329961","article-title":"Intrachromosomal amplification of chromosome 21 (iAMP21) is a primary genetic event in childhood B-cell precursor acute lymphoblastic leukaemia","volume":"117","author":"Rand","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0410","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/gcc.20412","article-title":"Intrachromosomal amplification of chromosome 21 (iAMP21) may arise from a breakage-fusion-bridge cycle","volume":"46","author":"Robinson","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.blre.2012.01.001_bb0415","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1073\/pnas.0602360103","article-title":"Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21","volume":"103","author":"Strefford","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2012.01.001_bb0420","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1182\/blood-2006-08-040436","article-title":"Prognosis of children with acute lymphoblastic leukaemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21)","volume":"109","author":"Moorman","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0425","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1200\/JCO.2008.16.1117","volume":"26","author":"Attarbaschi","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2012.01.001_bb0940","first-page":"118","article-title":"iAMP21 Is Associated with Inferior Outcomes in Children with Acute Lymphoblastic Leukemia (ALL) on Contemporary Children's Oncology Group (COG) Studies","author":"Heerema","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0435","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cancergencyto.2007.02.007","article-title":"Prognostic significance of cytogenetically detected chromosome 21 anomalies in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study","volume":"175","author":"Cooley","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.blre.2012.01.001_bb0440","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cancergencyto.2007.10.004","article-title":"Multiple copies of RUNX1: description of 14 new patients, follow-up, and a review of the literature","volume":"180","author":"Perez-Vera","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.blre.2012.01.001_bb0445","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2009-09-235986","article-title":"Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: rare clinical curios or potent genetic drivers?","volume":"115","author":"Dyer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0450","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1182\/blood-2006-08-041012","article-title":"Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)","volume":"109","author":"Akasaka","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0455","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1182\/blood-2006-03-010835","article-title":"Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia","volume":"108","author":"Chapiro","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0460","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/leu.2010.93","article-title":"A new recurrent translocation t(11;14)(q24;q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia","volume":"24","author":"Chapiro","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0465","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/blood-2007-07-092015","article-title":"t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)","volume":"111","author":"Russell","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0470","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/leu.2008.250","article-title":"A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin","volume":"23","author":"Russell","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0475","unstructured":"Moorman AV, Schwab C, Ensor HM, Russell LJ, Morrison H, Jones L, et al. IGH@ translocations, CRLF2 deregulation and micro-deletions in adolescents and adults with acute lymphoblastic leukemia. J. Clin. Oncol. in press."},{"key":"10.1016\/j.blre.2012.01.001_bb0480","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood-2009-03-208397","article-title":"Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia","volume":"114","author":"Russell","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0485","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/leu.2009.231","article-title":"Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia","volume":"24","author":"Chapiro","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0490","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1182\/blood-2009-08-235408","article-title":"Down syndrome acute lymphoblastic leukemia: a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the iBFM Study Group","volume":"115","author":"Hertzberg","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0495","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.469","article-title":"Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia","volume":"41","author":"Mullighan","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.blre.2012.01.001_bb0500","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1073\/pnas.0911726107","article-title":"Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia","volume":"107","author":"Yoda","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2012.01.001_bb0505","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1182\/blood-2010-07-297135","article-title":"Demographic, clinical and outcome features of children with acute lymphoblastic leukaemia and a CRLF2 rearrangement: results from the MRC ALL97 clinical trial","volume":"117","author":"Ensor","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0510","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1182\/blood-2009-09-245944","article-title":"Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic\/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia","volume":"115","author":"Harvey","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0515","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1182\/blood-2009-11-256131","article-title":"Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol","volume":"115","author":"Cario","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0530","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1182\/blood.V118.21.3579.3579","article-title":"Acute lymphoblastic leukemia in children with down syndrome: a report from the Ponte Di Legno study group","volume":"118","author":"Buitenkamp","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0535","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1200\/JCO.2009.24.8997","article-title":"Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12","volume":"28","author":"Harrison","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2012.01.001_bb0540","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities amongst 5,876 younger adult patients treated in the UK Medical Research Council trials","volume":"116","author":"Grimwade","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0545","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1182\/blood-2007-10-116186","article-title":"Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study","volume":"111","author":"Pullarkat","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0550","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1182\/blood.V110.11.3501.3501","article-title":"The prognostic significance of complex karyotype in Philadelphia chromosome-negative (Ph) acute lymphoblastic leukemia (ALL) in adults is related with risk group","volume":"110","author":"Granada","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0555","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1365-2141.2002.03442.x","article-title":"Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987\u20131999","volume":"117","author":"Chessells","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2012.01.001_bb0560","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/sj.leu.2405033","article-title":"Fusion of ZMIZ1 to ABL1 in a B-cell acute lymphoblastic leukaemia with a t(9;10)(q34;q22.3) translocation","volume":"22","author":"Soler","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0565","first-page":"5374","article-title":"Fusion of the homeobox gene HLXB9 and the ETV6 gene in infant acute myeloid leukemias with the t(7;12)(q36;p13)","volume":"61","author":"Beverloo","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.blre.2012.01.001_bb0570","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1098-2264(199803)21:3<223::AID-GCC6>3.0.CO;2-1","article-title":"Identification of new partner chromosomes involved in fusions with the ETV6 (TEL) gene in hematologic malignancies","volume":"21","author":"Tosi","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.blre.2012.01.001_bb0575","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.leu.2402121","article-title":"t(7;12)(q36;p13) and t(7;12)(q32;p13)\u2013translocations involving ETV6 in children 18 months of age or younger with myeloid disorders","volume":"15","author":"Slater","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0580","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/sj.leu.2402468","article-title":"Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party","volume":"16","author":"Chessells","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0585","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/sj.leu.2403842","article-title":"CIZ gene rearrangements in acute leukemia: report of a diagnostic FISH assay and clinical features of nine patients","volume":"19","author":"La Starza","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0590","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/cncr.10325","article-title":"Abnormalities of chromosome bands 15q13-15 in childhood acute lymphoblastic leukemia","volume":"94","author":"Heerema","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2012.01.001_bb0600","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1182\/blood-2009-01-199380","volume":"113","author":"Fielding","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0605","doi-asserted-by":"crossref","first-page":"6708","DOI":"10.1073\/pnas.0800408105","article-title":"Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: unexpected similarities with pediatric disease","volume":"105","author":"Paulsson","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2012.01.001_bb0610","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/leu.2009.203","article-title":"DNA copy-number abnormalities do not occur in infant ALL with t(4;11)\/MLL-AF4","volume":"24","author":"Bardini","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0615","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3324\/haematol.2009.011114","article-title":"Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia","volume":"95","author":"Okamoto","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2012.01.001_bb0620","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2008-07-166801","article-title":"A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukaemia reveals genomic deletion, copy number neutral loss of heterozygosity and association with specific cytogenetic subgroups","volume":"113","author":"Sulong","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0625","first-page":"1537","article-title":"Association of chromosome Arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer group","volume":"94","author":"Heerema","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0630","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.3324\/haematol.13227","article-title":"An investigation into whether deletions in 9p reflect prognosis in adult precursor B-cell acute lymphoblastic leukemia: a multi-center study of 381 patients","volume":"93","author":"Nahi","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2012.01.001_bb0635","first-page":"881","article-title":"The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951","volume":"91","author":"Mirebeau","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2012.01.001_bb0640","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.leukres.2008.01.014","article-title":"CDKN2A deletions in acute lymphoblastic leukemia of adolescents and young adults\u2013An array CGH study","volume":"32","author":"Usvasalo","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2012.01.001_bb0645","doi-asserted-by":"crossref","first-page":"17050","DOI":"10.1073\/pnas.0803494105","article-title":"Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer","volume":"105","author":"An","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2012.01.001_bb0650","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3324\/haematol.2008.002808","article-title":"Heterogeneous breakpoints in patients with acute lymphoblastic leukemia and the dic(9;20)(p11-13;q11) show recurrent involvement of genes at 20q11.21","volume":"94","author":"An","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2012.01.001_bb0655","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1038\/leu.2009.135","article-title":"PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study","volume":"23","author":"Familiades","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0660","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3324\/haematol.2009.020792","article-title":"The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party","volume":"95","author":"Iacobucci","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2012.01.001_bb0665","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2012.01.001_bb0670","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.leu.2401654","article-title":"Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia","volume":"14","author":"Clark","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0675","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2141.2006.06328.x","article-title":"Characterisation of dic(9;20)(p11-13;q11) in childhood B-cell precursor acute lymphoblastic leukaemia by tiling resolution array-based comparative genomic hybridisation reveals clustered breakpoints at 9p13.2 and 20q11.2","volume":"135","author":"Schoumans","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2012.01.001_bb0680","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/leu.2010.318","article-title":"The frequency and prognostic impact of dic(9;20)(p13.2;q11.2) in childhood B-cell precursor acute lymphoblastic leukemia: results from the NOPHO ALL-2000 trial","volume":"25","author":"Zachariadis","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0945","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/gcc.20517","article-title":"Clinical and cytogenetic features of pediatric dic(9;20)(p13.2;q11.2)-positive B-cell precursor acute lymphoblastic leukemias: a Nordic series of 24 cases and review of the literature","volume":"47","author":"Forestier","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.blre.2012.01.001_bb0690","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2009.08059.x","article-title":"Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Munster (BFM) protocols containing an intensive induction and post-induction consolidation therapy","volume":"149","author":"Pichler","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2012.01.001_bb0695","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1182\/blood-2007-09-112631","article-title":"Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance","volume":"112","author":"Iacobucci","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0700","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood-2008-08-173963","volume":"114","author":"Iacobucci","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0705","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1200\/JCO.2008.21.6408","article-title":"IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report","volume":"27","author":"Martinelli","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2012.01.001_bb0710","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1182\/blood-2009-08-239681","article-title":"Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome","volume":"116","author":"Harvey","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0715","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/leu.2010.275","article-title":"Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia","volume":"25","author":"Waanders","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0720","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/leu.2010.87","article-title":"IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL","volume":"24","author":"Kuiper","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0730","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1182\/blood.V118.21.3518.3518","article-title":"Poor prognosis for IKZF1 intra-gene deletions in pediatric Ph- B-cell precursor acute lymphoblastic leukemia","volume":"118","author":"Palmi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0735","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1182\/blood.V118.21.1455.1455","article-title":"IKZF1 deletion is strongly associated with risk of relapse in intermediate risk group in JACLS ALL02 cohort","volume":"118","author":"Asai","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0740","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1182\/blood.V118.21.3539.3539","article-title":"Gene microdeletions in adult and pediatric acute lymphoblastic leukemia","volume":"118","author":"G\u00f3mez-Segu\u00ed","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0745","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood.V118.21.572.572","volume":"118","author":"Beldjord","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0750","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1200\/JCO.2000.18.22.3837","article-title":"Abnormalities of chromosome bands 13q12 to 13q14 in childhood acute lymphoblastic leukemia","volume":"18","author":"Heerema","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2012.01.001_bb0755","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1182\/blood.V87.3.1155.bloodjournal8731155","article-title":"High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis","volume":"87","author":"Marks","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0760","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1200\/JCO.2011.34.8144","article-title":"Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia","volume":"29","author":"Hof","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2012.01.001_bb0765","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1200\/JCO.2010.30.7405","article-title":"Biology, risk stratification, and therapy of pediatric acute leukemias: an update","volume":"29","author":"Pui","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2012.01.001_bb0770","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2141.2010.08312.x","article-title":"Application of genomics for risk stratification of childhood acute lymphoblastic leukaemia: from bench to bedside?","volume":"151","author":"Izraeli","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2012.01.001_bb0775","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/pbc.22628","article-title":"Frequencies of ETV6-RUNX1 fusion and hyperdiploidy in pediatric acute lymphoblastic leukemia are lower in far east than west","volume":"55","author":"Liang","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2012.01.001_bb0780","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.blre.2012.01.001_bb0785","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrc2091","article-title":"The impact of translocations and gene fusions on cancer causation","volume":"7","author":"Mitelman","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.blre.2012.01.001_bb0790","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/blood-2011-03-341412","article-title":"Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group","volume":"118","author":"Zhang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0795","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.1158\/0008-5472.CAN-08-0101","article-title":"Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia","volume":"68","author":"Case","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.blre.2012.01.001_bb0800","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/gcc.20502","article-title":"Mutations of FLT3, NRAS, KRAS, and PTPNII are frequent and possibly mutually exclusive in high hyperdiploid childhood acute lymphoblastic leukemia","volume":"47","author":"Paulsson","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.blre.2012.01.001_bb0805","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/S0140-6736(08)61341-0","article-title":"Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome","volume":"372","author":"Bercovich","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2012.01.001_bb0810","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature09727","article-title":"CREBBP mutations in relapsed acute lymphoblastic leukaemia","volume":"471","author":"Mullighan","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.blre.2012.01.001_bb0815","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1470-2045(08)70229-8","article-title":"Bone-marrow relapse in paediatric acute lymphoblastic leukaemia","volume":"9","author":"Bailey","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.blre.2012.01.001_bb0820","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2141.2008.07513.x","article-title":"Optimal management of adults with ALL","volume":"144","author":"Rowe","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2012.01.001_bb0825","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/S0140-6736(10)62002-8","article-title":"Mitoxantrone improves outcome of children with first relapse of acute lymphoblastic leukemia \u2013 results of the randomized ALLR3 trial","volume":"376","author":"Parker","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2012.01.001_bb0830","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1182\/blood-2010-07-294678","article-title":"Postrelapse survival in childhood acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group","volume":"117","author":"Freyer","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0835","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1200\/JCO.2009.25.1983","article-title":"Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90","volume":"28","author":"Tallen","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2012.01.001_bb0840","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood-2006-05-018192","article-title":"Outcome of 609 adults after relapse of acute lymphoblastic leukaemia (ALL); an MRC UKALL12\/ECOG 2993 study","volume":"109","author":"Fielding","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0845","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/08880019409140537","article-title":"Frequency and importance of change in blast cell karyotype in relapsing childhood lymphoblastic leukemia","volume":"11","author":"Vora","year":"1994","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2012.01.001_bb0850","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cancergencyto.2008.10.002","article-title":"Non-classical karyotypic features in relapsed childhood B-cell precursor acute lymphoblastic leukemia","volume":"189","author":"Wehrli","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.blre.2012.01.001_bb0855","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2141.2008.07499.x","article-title":"Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria\u2013a population-based report of the Austrian Berlin-Frankfurt-Munster (BFM) Study Group","volume":"144","author":"Reismuller","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2012.01.001_bb0860","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1126\/science.1164266","article-title":"Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia","volume":"322","author":"Mullighan","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.blre.2012.01.001_bb0865","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature09650","article-title":"Genetic variegation of clonal architecture and stem cells in leukaemia","volume":"469","author":"Anderson","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.blre.2012.01.001_bb0870","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/leu.2010.39","article-title":"Relapsed childhood high hyperdiploid acute lymphoblastic leukemia: presence of preleukemic ancestral clones and the secondary nature of microdeletions and RTK-RAS mutations","volume":"24","author":"Davidsson","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0875","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1182\/blood-2008-06-165027","article-title":"Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia","volume":"112","author":"Yang","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2012.01.001_bb0880","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1535-6108(02)00032-6","article-title":"Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling","volume":"1","author":"Yeoh","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.blre.2012.01.001_bb0885","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/leu.2008.286","article-title":"Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia","volume":"23","author":"Schotte","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0890","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/leu.2008.130","article-title":"Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia","volume":"22","author":"Kuang","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2012.01.001_bb0895","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1470-2045(08)70339-5","article-title":"A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study","volume":"10","author":"Den Boer","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.blre.2012.01.001_bb0900","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1182\/blood-2011-04-345595","article-title":"Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies","volume":"118","author":"Hogan","year":"2011","journal-title":"Blood"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X12000021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X12000021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T09:21:01Z","timestamp":1593854461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X12000021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":176,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0268960X12000021"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2012.01.001","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}